GlaxoSmithKline has appointed Judy Lewent to its board as a non-executive director. She has previously served as an executive VP …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

